EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Feasibility of Customized Thermoplastic Patient-Specific Helmet Bolus for Scalp Irradiation Using Volumetric-Modulated Arc Therapy Planning

Heesoo Kim, Jeong-Woo Lee iD, Semie Hong

Technology in Cancer Research & Treatment · 2024

DOI: 10.1177/15330338241241898 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, 2024. Verfasst von Heesoo Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Konkuk University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Radiotherapy, Intensity-Modulated. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

In this study, we sought to develop a thermoplastic patient-specific helmet bolus that could deliver a uniform therapeutic dose to the target and minimize the dose to the normal brain during whole-scalp treatment with a humanoid head phantom.

Methods

The bolus material was a commercial thermoplastic used for patient immobilization, and the holes in the netting were filled with melted paraffin. We compared volumetric-modulated arc therapy treatment plans with and without the bolus for quantitative dose distribution analysis. We analyzed the dose distribution in the region of interest to compare dose differences between target and normal organs. For quantitative analysis of treatment dose, OSLD chips were attached at the vertex (VX), posterior occipital (PO), right (RT), and left temporal (LT) locations.

Results

The average dose in the clinical target volume was 6553.8 cGy (99.3%) with bolus and 5874 cGy (89%) without bolus, differing by more than 10% from the prescribed dose (6600 cGy) to the scalp target. For the normal brain, it was 3747.8 cGy (56.8%) with bolus and 5484.6 cGy (83.1%) without bolus. These results show that while the dose to the treatment target decreased, the average dose to the normal brain, which is mostly inside the treatment target, increased by more than 25%. With the bolus, the OSLD measured dose was 102.5 ± 1.2% for VX and 101.5 ± 1.9%, 95.9 ± 1.9%, and 81.8 ± 2.1% for PO, RT, and LT, respectively. In addition, the average dose in the treatment plan was 102%, 101%, 93.6%, and 80.7% for VX, PO, RT, and LT. When no bolus was administered, 59.6 ± 2.4%, 112.6 ± 1.8%, 47.1 ± 1.6%, and 53.1 ± 2.3% were assessed as OSLD doses for VX, PO, RT, and LT, respectively.

Conclusion

This study proposed a method to fabricate patient-specific boluses that are highly reproducible, accessible, and easy to fabricate for radiotherapy to the entire scalp and can effectively spare normal tissue while delivering sufficient surface dose.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Radiotherapy, Intensity-ModulatedHumansFeasibility StudiesHead Protective DevicesOrgans at RiskRadiotherapy DosageRadiotherapy Planning, Computer-AssistedScalp

Stichwörter der Autor:innen

OSLDVMAThead phantomscalpthermoplastic patient-specific helmet bolus

Autor:innen und Institutionen

  • Konkuk University, Seoul, Republic of Korea.
  • Yonsei Cancer Center, Seoul, Republic of Korea.
  • Konkuk University Medical Center, Seoul, Republic of Korea.

ORCID-Profile: Jeong-Woo Lee

Zitieren

APA

Kim, H., Lee, J. W., & Hong, S. (2024). Feasibility of Customized Thermoplastic Patient-Specific Helmet Bolus for Scalp Irradiation Using Volumetric-Modulated Arc Therapy Planning. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338241241898

Vancouver

Kim H, Lee JW, Hong S. Feasibility of Customized Thermoplastic Patient-Specific Helmet Bolus for Scalp Irradiation Using Volumetric-Modulated Arc Therapy Planning. Technology in Cancer Research & Treatment. 2024. doi:10.1177/15330338241241898

BibTeX
@article{Kim2024,
  author = {Kim, Heesoo and Lee, Jeong-Woo and Hong, Semie},
  title = {Feasibility of Customized Thermoplastic Patient-Specific Helmet Bolus for Scalp Irradiation Using Volumetric-Modulated Arc Therapy Planning},
  journal = {Technology in Cancer Research & Treatment},
  year = {2024},
  doi = {10.1177/15330338241241898}
}
Kostenlos starten →